Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
42 results
- D1.340 - Attack burden and patient-reported outcomes in adults with hereditary angioedema: associations with quality of life, pain, and coping strategies
- D1.336 - Barriers to Normalization with Existing Treatments Among People Living with Hereditary Angioedema in Europe
- D1.337 - Long-Term Safety, Tolerability, and Effectiveness of Berotralstat in Hereditary Angioedema: Interim Analysis of the APeX-N Post-Authorization Study
- D1.338 - Divergent Clinical and Functional Consequences of Canonical NF-κB Pathway Defects
- D1.339 - Renal and urinary tract disorders in inborn errors of immunity
- D1.341 - Severe Atopic Features with Prematurity and Ichthyosis: Ichthyosis Prematurity Syndrome
- D1.342 - Case Report: Off-Label Dosage of Berotralstat in Hereditary Angioedema
- D1.343 - Common Variable Immunodeficiency Associated Enteropathy: A Single-Center Experience
- D1.344 - Hidden Immunodeficiency in Adult Bronchiectasis: Lymphocyte Subsets, Humoral Defects, and Genetic Findings
- D1.346 - Clinically significant gastrointestinal endoscopic findings in asymptomatic patients with common variable immunodeficiency
- D1.347 - Lanadelumab in Children with Hereditary Angioedema Aged 2 to
D1.496 - Variation in platelet-activating factor levels among patients with chronic spontaneous urticaria
D1.507 - Biomarkers of T2-airway inflammation in patients with asthma and COPD overlap
D1.495 - Noninvasive Monitoring of Cutaneous Molecular Changes During Improvement of Infantile Atopic Dermatitis: Application of Skin Surface Lipid RNA (SSL-RNA) Analysis
D1.497 - An integrated multiomic insight to nonsteroidal anti-inflammatory drug-induced acute urticaria/angioedema
D1.498 - Altered B Cell Dynamics in Childhood-Onset Systemic Lupus Erythematosus: Insights from Disease States and Rituximab Treatment
D1.499 - A clinically validated kinin biomarker assay to differentiate bradykinin-mediated from mast cell-mediated angioedema
D1.503 - Immunoglobulin Abnormalities in Cronkhite-Canada Syndrome: A Focus on IgE and IgG4
D1.504 - Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: Clinical Characteristics and Outcomes in a series of pediatric cases
D1.505 - Impact of patient factors on the stability of anti-IgE treatment response in chronic spontaneous urticaria
Pagination
Current page
1
Page
2
Page
3
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download